Management of Elevated Liver Enzymes (ALP 160, GGT 90, ALT 70)
Your patient has a mixed hepatocellular-cholestatic pattern requiring a comprehensive liver etiology screen, fibrosis risk stratification with FIB-4 score, and repeat testing in 2-4 weeks to establish a trend. 1, 2
Pattern Recognition
Your enzyme pattern shows:
- Mild ALT elevation (hepatocellular component) 2, 3
- Elevated ALP and GGT (cholestatic component) 1
- This mixed pattern suggests early cholestatic disease, infiltrative liver disease, or metabolic liver disease 1
The elevations are mild (<3× upper limit of normal), which typically warrants systematic evaluation rather than immediate intervention 2
Immediate Diagnostic Workup
Standard liver etiology screen should include: 1
- Viral hepatitis serologies (Hepatitis A, B, C, E) 1, 3
- Autoimmune markers (ANA, ASMA, anti-LKM, immunoglobulins) 1
- Iron studies (ferritin, transferrin saturation) 1
- Ceruloplasmin (for Wilson's disease if age <40) 3
- Complete metabolic panel including albumin, bilirubin, INR 2, 3
- Complete blood count and platelet count 2
Alcohol assessment is mandatory: 1, 3
- Perform AUDIT-C screening 1
- If positive, complete full 10-item AUDIT 1
- Alcohol is the second most common cause of elevated liver enzymes after NAFLD 4
Metabolic risk factor assessment: 5, 3
- Screen for metabolic syndrome components (waist circumference, blood pressure, fasting glucose, triglycerides, HDL cholesterol) 5
- Calculate BMI and assess for diabetes, dyslipidemia, hypertension 3
- NAFLD is the most common cause (30-40%) of elevated liver enzymes 4
Fibrosis Risk Stratification
Calculate FIB-4 score immediately: 1
- Formula: (Age × AST) / (Platelet count × √ALT) 1
- Score >2.67 indicates high risk of advanced fibrosis requiring hepatology referral 1
- Score 1.3-2.67 is intermediate risk requiring second-line assessment 1
If FIB-4 is elevated or intermediate, perform second-line fibrosis assessment: 1
- Serum ELF test or FibroScan/ARFI elastography 1
Special Considerations for Your Cholestatic Pattern
Given elevated ALP and GGT, consider: 1
- Primary sclerosing cholangitis (PSC), especially if personal/family history of autoimmune disease or inflammatory bowel disease 1
- Obtain abdominal ultrasound to exclude biliary obstruction 4
- Check for infiltrative diseases if other workup negative 6
Medication Review
Systematically review all medications for hepatotoxicity: 3
- NSAIDs, statins, antibiotics, herbal supplements 3
- Drug-induced liver injury accounts for 8-11% of elevated liver enzymes 4
Follow-up Timeline
Repeat liver enzymes in 2-4 weeks: 2, 3
- Establish trend (increasing, stable, or decreasing) 2, 3
- Include complete liver panel (ALT, AST, ALP, GGT, bilirubin, albumin) 2
- Note: 84% of mild elevations remain abnormal on retesting after 1 month 2
If enzymes remain elevated after addressing modifiable factors: 1, 2
- Repeat testing every 3-6 months initially 1
- Continue monitoring until diagnosis established or normalization occurs 1
Referral Criteria to Hepatology/Gastroenterology
- FIB-4 score >2.67 or other evidence of advanced fibrosis 1
- ALT continues to rise or remains >2× ULN after 3 months despite addressing modifiable factors 3
- Extended liver etiology screen is negative and no risk factors for NAFLD identified 1
- Evidence of synthetic dysfunction (elevated INR, low albumin) 3
- Clinical signs of chronic liver disease or cirrhosis 3
Common Pitfalls to Avoid
- Do not ignore mild elevations - they require systematic evaluation 2
- Do not simply repeat the same tests without a diagnostic plan 2
- Do not overlook medication review and alcohol assessment - these are the most modifiable factors 2, 3
- Do not assume normal imaging excludes significant liver disease - fibrosis assessment is still needed 1
- Do not delay alcohol cessation counseling - if AUDIT score >19, refer to alcohol services 3
Management of Modifiable Risk Factors
If NAFLD-related (most common cause): 5, 3
- Lifestyle modifications with weight loss target of 7-10% body weight 5
- Increase physical activity 5
- Dietary counseling to reduce saturated fats, refined carbohydrates, and sugar-sweetened beverages 5
If alcohol-related: 3